SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039327
Filing Date
2020-08-11
Accepted
2020-08-11 16:24:21
Documents
83
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-10q_20200630.htm 10-Q 2930289
2 EX-3.1 plrx-ex31_301.htm EX-3.1 41217
3 EX-3.2 plrx-ex32_300.htm EX-3.2 136187
4 EX-31.1 plrx-ex311_8.htm EX-31.1 17188
5 EX-31.2 plrx-ex312_6.htm EX-31.2 17114
6 EX-32.1 plrx-ex321_7.htm EX-32.1 8637
  Complete submission text file 0001564590-20-039327.txt   9978041

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT plrx-20200630.xml EX-101.INS 1926072
8 XBRL TAXONOMY EXTENSION SCHEMA plrx-20200630.xsd EX-101.SCH 70196
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plrx-20200630_cal.xml EX-101.CAL 41503
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plrx-20200630_def.xml EX-101.DEF 325832
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20200630_lab.xml EX-101.LAB 527879
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20200630_pre.xml EX-101.PRE 465242
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 201092753
SIC: 2834 Pharmaceutical Preparations